Outcome of Women With Cervical Cancer

September 5, 2016 updated by: Sheng-Mou Hsiao, Far Eastern Memorial Hospital

Squamous cell carcinoma (SCC) of the cervix has showed a marked decline in developed countries over the past 40 years, however, there has also been an increase in relative and absolute incidence of adenocarcinoma and adenosquamous carcinoma (AC) of the uterine cervix over the same period.

Our understanding of the natural history and optimal management of AC is limited. It appears that AC and SCC of the cervix behave differently. They are different in epidemiology, prognostic factors, and patterns of failure after similar treatments. Available data suggest that they may also differ in their response to treatment. We postulate that new treatment strategies specifically tailored to AC should be explored.

However, there is few data about outcome of cervical cancer in Taiwan. So we propose this proposal for retrospective analysis of clinicopathological parameters and outcomes in patients of cervical cancer, especially for cervical adenocarcinoma and adenosquamous carcinoma.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

81

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taipei
      • Banqiao, Taipei, Taiwan, 22050
        • Far Eastern Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 99 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

the cases with cervical cancer

Description

Inclusion Criteria:

  • Time interval: from 1991 to date.
  • Comprehensive surgical staging, debulking procedure, radiotherapy or chemotherapy.
  • All female patients with cervical cancer who underwent treatment for cervical cancer at Far Eastern Memorial Hospital.
  • All the patients diagnosed as cervical cancer, especially for women with adeno- and adenosquamous carcinoma.
  • To review:

    1. Clinical data: including age at diagnosis, presenting symptoms, gravidity, parity, menstrual history, body mass index, history of diabetes, hypertension, personal history of cancer and staging.
    2. Pathologic information: deep stromal invasion, lymph-vascular space invasion, lymph node involvement, parametrium invasion, vaginal cut end and tumor size.
    3. Survival data: disease-free and overall survival.
    4. Radiation report, Chemotherapy treatment, operation, discharge and admission note.

Exclusion Criteria:

  • Not comprehensive staging/debulking procedure.
  • Patients who died of postoperative complications within 30 days after surgery were excluded from the survival analysis.
  • Female minors or disabled persons.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
cases with cervical cancer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Outcome of women with cervical cancer
Time Frame: 20 years
20 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (ACTUAL)

November 1, 2015

Study Completion (ACTUAL)

May 1, 2016

Study Registration Dates

First Submitted

January 1, 2014

First Submitted That Met QC Criteria

January 1, 2014

First Posted (ESTIMATE)

January 3, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

September 7, 2016

Last Update Submitted That Met QC Criteria

September 5, 2016

Last Verified

February 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 102159-E

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.